Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability
Top Cited Papers
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (10) , 1123-1127
- https://doi.org/10.1038/nm1001-1123
Abstract
Polymorphonuclear leukocyte infiltration into tissues in host defense and inflammatory disease causes increased vascular permeability and edema formation through unknown mechanisms. Here, we report the involvement of a paracrine mechanism in neutrophil-evoked alteration in endothelial barrier function. We show that upon neutrophil adhesion to the endothelial lining, leukocytic β2 integrin signaling triggers the release of neutrophil-borne heparin-binding protein (HBP), also known as CAP37/azurocidin, a member of the serprocidin family of neutrophil cationic proteins. HBP induced Ca++-dependent cytoskeletal rearrangement and intercellular gap formation in endothelial-cell monolayers in vitro, and increased macromolecular efflux in microvessels in vivo. Moreover, selective inactivation of HBP prevented the neutrophils from inducing endothelial hyperpermeability. Our data suggest a fundamental role of neutrophil-derived HBP in the vascular response to neutrophil trafficking in inflammation. Targeting this molecule in inflammatory disease conditions offers a new strategy for prevention of endothelial barrier dysfunction caused by misdirected leukocyte activation.Keywords
This publication has 29 references indexed in Scilit:
- Modulation of epithelial and endothelial paracellular permeability by leukocytesAdvanced Drug Delivery Reviews, 2000
- Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosisJournal of Clinical Investigation, 1999
- AprotininDrugs, 1999
- Kinetics of leukocyte‐induced changes in endothelial barrier functionBritish Journal of Pharmacology, 1998
- Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation‐enhancing LPS‐induced cytokine release from monocytesFEBS Letters, 1996
- Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated NeutrophilsJournal of Biological Chemistry, 1996
- Binding of bovine pancreatic trypsin inhibitor to heparin binding protein/CAP37/azurocidinEuropean Journal of Biochemistry, 1993
- Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteasesBiochemical and Biophysical Research Communications, 1991
- Covalent structure of two novel neutrophile leucocyte‐derived proteins of porcine and human originEuropean Journal of Biochemistry, 1991
- CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity.Journal of Clinical Investigation, 1990